Singapore, Nov. 14 -- Sanofi on 13 Nov 2019, announced the launch of SOLIQUA(R), its once-daily injectable treatment which aims to relieve the burden of uncontrolled type 2 diabetes (T2D) in Singapore in a simple, single step.

Uncontrolled diabetes is a growing threat and occurs when the blood sugar level of a patient with type 2 diabetes is above the recommended target range set by their doctor. It is reported in as many as half of patients with type 2 diabetes who are using medication.This may be due to factors such as the severity of the condition, non-adherence to lifestyle changes or the complex regimens of treatment required by patients, which may include multiple injections throughout the day

Dr Khoo Chin Meng (Head & Senior Cons...